Scholars Central

Research articlePublished 26 Oct 2023

Alpha lipoic acid a boon for diabetic peripheral neuropathy: A systematic review and meta-analysis.

Authors: Pingali Usha Rani, Mekala Padmaja, Kammila Sireesha, Penugonda Sravanasandhya

Biomedical Research

Volume 34 · Issue 4 · Pages 1–8

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Diabetic Peripheral Neuropathy (DPN) is the most prevalent chronic microvascular complication in both type 1 and type 2 Diabetes Mellitus (DM) patients. In type 2 DM, insulin resistance affects vascular endothelium resulting in endothelial dysfunction, platelet hyperactivity and oxidative stress. Alpha Lipoic Acid (ALA) a potent antioxidant, targets oxidative stress in DPN which improves nerve blood flow, distal nerve conduction, and neuropathic symptoms. Herein, we planned to review the efficacy of ALA in improving symptoms of DPN without affecting glycaemic control. Objective: To evaluate efficacy and safety ofA LA on neuropathic symptoms in DPN. Methods: A systemic search was conducted to collect and analyse all studies published from 1995 to 2020 that investigated effect of ALA on neuropathic symptoms in diabetic neuropathy patients using the phrase “Alpha lipoic acid and diabetic neuropathy". Studies were extracted from PubMed and CTRI. The Randomized Controlled Trials (RCT) which investigated effects of ALA in DPN patients were included whereas nonrandomized trials and clinical observations were excluded. The RevMan Manager 5.4 software was used for meta-analysis. The results were expressed as Weighted Mean Difference (WMD) with 95% confidence intervals (95% CIs) using a Fixed Effect (FE) or Randomized Effect (RE) model. Results: Eight RCTs met inclusion criteria. Treatment group received ALA of 300-1800 mg per day and control group received a placebo. Compared with placebo, ALA showed significant improvement in symptoms of DPN. There were no serious adverse events during treatment period. Conclusion: Our systemic review indicates a favourable effect of ALA on neuropathic symptoms in DPN patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomedical Research
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Pingali Usha Rani”
  • BylineArticles whose byline prints “Mekala Padmaja”
  • BylineArticles whose byline prints “Kammila Sireesha”
  • BylineArticles whose byline prints “Penugonda Sravanasandhya”